Power Law company profile

TG Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2011 · IPO 2003 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$5.47B

Market cap · Apr/2026

Revenue

$616M

Latest reported FY

Global footprint

Where TG Therapeutics has talent and traffic

Web traffic by country

40K monthly visits
across markets

🇺🇸 United States20%

🇨🇦 Canada4%

🇬🇧 United Kingdom3.5%

🇯🇵 Japan3.3%

🇮🇳 India3%

Top 5 markets shown

Patent intelligence

$675k patent portfolio · 7 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$675k

0.01% of market cap · 485.8× smaller than top peer Genmab ($328M)

7 active patent families

Where TG Therapeutics innovates Antiendomysial antibodiesMolecular biologyAnti antibodyImmunologyKinase

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

TG Therapeutics on the five Patsnap quality dimensions

TG Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where TG Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across TG Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See TG Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo